18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma

Gut

Volumn 52, Issue 3, 2003, Pages 347-351

  Hoffmann, M ^a   Vogelsang, H ^a   Kletter, K ^a   Zettinig, G ^a   Chott, A ^a   Raderer, M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; ENTEROPATHY TYPE T CELL LYMPHOMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; JEJUNUM; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; T CELL LYMPHOMA; WHOLE BODY SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; CELIAC DISEASE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, SMALL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0037371152     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.3.347     Document Type: Article

References (29)

1. Isaacson PG. Gastrointestinal lymphomas of T- and B-cell types. Mod Pathol 1999;12:151-8.
2. Chott A, Vesely M, Simonitsch I, et al. Classification of intestinal T-cell neoplasms and their differential diagnosis. Am J Clin Pathol 1999;111 (suppl 1):S68-74.
3. Chott A, Haedicke W, Mosberger I, et al. Most CD56+ intestinal lymphomas are CD8+ CD5- T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 1998;153:1483-90.
4. International Lymphoma Study Group. The Non-Hodgkin's Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997;89:3909-18.
5. Chott A, Dragosics B, Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. Am J Pathol 1992;141:1361-71.
6. Isaacson PG, Wright DH. Intestinal lymphoma associated with malabsorption. Lancet 1978;2:67-70.
7. Isaacson PG, O'Connor N, Spencer J, et al. Malignant histiocytosis of the intestine: a T-cell lymphoma. Lancet 1985;2:688-91.
8. Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumours: tumours of hematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
9. Isaacson PG, Wright D, Ralfkiaer E, et al. Enteropathy-type T-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. World Health Organization classification of tumours: tumours of hematopoietic and lymphoid tissues. Lyon: IARC Press, 2001:208-9.
10. Isaacson PG. Gastrointestinal lymphoma. Hum Pathol 1994;25:1020-9.
11. Daum S, Weiss D, Hummel M, et al. Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue. Gut 2001;49:804-12.
12. Holmes G, Stokes PL, Sorahan TM, et al. Coeliac disease, gluten-free diet, and malignancy. Gut 1976;17:612-19.
13. Holmes G, Prior P, Lane M, et al. Malignancy in coeliac disease - effect of gluten free diet. Gut 1989;30:333-8.
14. Bagdi E, Diss T, Munson P, et al. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis and refractory celiac disease constitute a neoplastic population. Blood 1999;94:260-4.
15. Gale J, Simmonds P, Mead G, et al. Enteropathy-type intestinal T-cell lymphoma: Clinical features and treatment of 31 patients in a single center. J Clin Oncol 2000;18:795-803.
16. Rigo P, Paulus P, Kaschten BJ, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodesoxyglucose. Eur J Nucl Med 1996;23:1641-74.
17. Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol 2001;2:157-64.
18. Czernin J, Phelps ME. Positron emission tomography scanning: current and future applications. Annu Rev Med 2002;53:89-112.
19. Schoder H, Meta J, Yap C, et al. Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. J Nucl Med 2001;42:1139-43.
20. Segall GM. FDG PET imaging in patients with lymphoma: a clinical perspective. Nucl Med 2001;42:609-10.
21. Hoffmann M, Kletter K, Diemling M, et al. Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type. Ann Oncol 1999;10:1185-9.
22. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185-94.
23. Ferreira M, Davies SL, Butler M, et al. Endomysial antibody: is it the best screening test for coeliac diseose? Gut 1992;33:1633-7.
24. Zhuang H, Pourdehnad M, Lambright ES, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001;42:1412-17.
25. Bakheet SM, Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 1998;28:352-8.
26. Sugawara Y, Braun DK, Kison PV, et al.I. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 1998;25:1238-43.
27. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumours: standardized uptake value in 52 lesions. Radiology 2001;219:774-7.
28. Huang SC. Anatomy of SUV. Standardized uptake value. Nucl Med Biol 2000;27:643-6.
29. Lowe VJ, Fletcher JW, Gobar L, et al.I. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998;16:1075-84.